Texas Permanent School Fund lessened its position in Halyard Health Inc (NYSE:HYH) by 7.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 31,630 shares of the medical instruments supplier’s stock after selling 2,530 shares during the period. Texas Permanent School Fund’s holdings in Halyard Health were worth $1,461,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Jarislowsky Fraser Ltd bought a new position in shares of Halyard Health in the third quarter worth approximately $200,000. Quotient Investors LLC bought a new position in shares of Halyard Health in the third quarter worth approximately $203,000. Jane Street Group LLC bought a new position in shares of Halyard Health in the third quarter worth approximately $211,000. QS Investors LLC lifted its stake in shares of Halyard Health by 305.6% in the second quarter. QS Investors LLC now owns 5,176 shares of the medical instruments supplier’s stock worth $203,000 after buying an additional 3,900 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. bought a new position in shares of Halyard Health in the second quarter worth approximately $217,000. Hedge funds and other institutional investors own 89.34% of the company’s stock.

Halyard Health Inc (NYSE:HYH) opened at $45.38 on Friday. The company has a current ratio of 2.13, a quick ratio of 1.19 and a debt-to-equity ratio of 0.49. Halyard Health Inc has a twelve month low of $35.24 and a twelve month high of $50.99. The firm has a market cap of $2,125.42, a P/E ratio of 21.71, a PEG ratio of 2.38 and a beta of 1.71.

Several research analysts have recently issued reports on the stock. Zacks Investment Research downgraded shares of Halyard Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 1st. TheStreet upgraded shares of Halyard Health from a “c+” rating to a “b” rating in a research note on Monday, December 4th. ValuEngine upgraded shares of Halyard Health from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Stifel Nicolaus reiterated a “buy” rating and issued a $52.00 target price on shares of Halyard Health in a research note on Friday, November 3rd. Finally, KeyCorp reiterated a “hold” rating on shares of Halyard Health in a research note on Tuesday, October 17th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $49.00.

TRADEMARK VIOLATION WARNING: This article was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://theolympiareport.com/2018/02/11/texas-permanent-school-fund-has-1-46-million-stake-in-halyard-health-inc-hyh.html.

About Halyard Health

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health Inc (NYSE:HYH).

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.